BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models. - Li, D.; Ambrogio, L.; Shimamura, T.; Kubo, S.; Takahashi, M.; Chirieac, L. R.; Padera, R. F.; Shapiro, G. I.; Baum, A.; Himmelsbach, F.; Rettig, W. J.; Meyerson, M.; et al. (Oncogene, 2008)